Crouse Steven C. 4

What Happened

• Steven C. Crouse, President — Diagnostic & Spatial Biology at Bio-Techne (TECH), had 794 restricted stock units (RSUs) convert into 794 common shares on May 1, 2026. Of those shares, 311 were withheld to satisfy tax withholding at $55.02 per share, generating proceeds of $17,111. The filing shows a separate derivative conversion entry (code M) recording the RSU-to-share conversion at $0 — this is a bookkeeping entry reflecting the derivative’s termination, not a sale of shares.

Key Details

• Transaction date: 2026-05-01; filing date: 2026-05-05 (filed timely).
• What occurred: Conversion/exercise of 794 RSUs into common stock (code M) and tax-withholding disposition of 311 shares (code F) at $55.02/share for $17,111.
• Net shares delivered to insider: 794 vested − 311 withheld = 483 shares received.
• Footnotes: F1 confirms each RSU = 1 share; F2 notes the 794 RSUs vest on 5/1/2026 (and again on 5/1/2027).
• Shares owned after transaction: Not specified in the provided filing extract.

Context

• This was a vesting/settlement of restricted stock units, not an open-market purchase or sale. The tax-withholding (F) entry is routine — shares are surrendered to cover withholding obligations. The derivative (M) entry at $0 simply records conversion/termination of the RSU award and should not be read as a market sale.